Nautilus Biotechnology, Inc.: Form SCHEDULE 13D/A, filed Sep 11, 2026
Filed with the SEC on Sep 11, 2026 and accepted by EDGAR at Sep 11, 2026, 17:08 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001231919-26-001165. Last ingested by Listed: Nov 3, 2026, 18:40 ET. Listed shows no prices and gives no investment advice.